BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20370592)

  • 1. Engineered cystine-knot miniproteins for diagnostic applications.
    Kolmar H
    Expert Rev Mol Diagn; 2010 Apr; 10(3):361-8. PubMed ID: 20370592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative binding proteins: biological activity and therapeutic potential of cystine-knot miniproteins.
    Kolmar H
    FEBS J; 2008 Jun; 275(11):2684-90. PubMed ID: 18435757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological diversity and therapeutic potential of natural and engineered cystine knot miniproteins.
    Kolmar H
    Curr Opin Pharmacol; 2009 Oct; 9(5):608-14. PubMed ID: 19523876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular evolution of cystine-stabilized miniproteins as stable proteinaceous binders.
    Chang HJ; Hsu HJ; Chang CF; Peng HP; Sun YK; Yu HM; Shih HC; Song CY; Lin YT; Chen CC; Wang CH; Yang AS
    Structure; 2009 Apr; 17(4):620-31. PubMed ID: 19368895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural and engineered cystine knot miniproteins for diagnostic and therapeutic applications.
    Kolmar H
    Curr Pharm Des; 2011 Dec; 17(38):4329-36. PubMed ID: 22204431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cyclotide family of circular miniproteins: nature's combinatorial peptide template.
    Craik DJ; Cemazar M; Wang CK; Daly NL
    Biopolymers; 2006; 84(3):250-66. PubMed ID: 16440288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New binding specificities derived from Min-23, a small cystine-stabilized peptidic scaffold.
    Souriau C; Chiche L; Irving R; Hudson P
    Biochemistry; 2005 May; 44(19):7143-55. PubMed ID: 15882053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineered cystine knot miniproteins as potent inhibitors of human mast cell tryptase beta.
    Sommerhoff CP; Avrutina O; Schmoldt HU; Gabrijelcic-Geiger D; Diederichsen U; Kolmar H
    J Mol Biol; 2010 Jan; 395(1):167-75. PubMed ID: 19852971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel miniproteins engineered by the transfer of active sites to small natural scaffolds.
    Vita C; Vizzavona J; Drakopoulou E; Zinn-Justin S; Gilquin B; Ménez A
    Biopolymers; 1998; 47(1):93-100. PubMed ID: 9692330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermal, chemical, and enzymatic stability of the cyclotide kalata B1: the importance of the cyclic cystine knot.
    Colgrave ML; Craik DJ
    Biochemistry; 2004 May; 43(20):5965-75. PubMed ID: 15147180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioactive cystine knot proteins.
    Daly NL; Craik DJ
    Curr Opin Chem Biol; 2011 Jun; 15(3):362-8. PubMed ID: 21362584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marked increase in membranolytic selectivity of novel cyclic tachyplesins constrained with an antiparallel two-beta strand cystine knot framework.
    Tam JP; Lu YA; Yang JL
    Biochem Biophys Res Commun; 2000 Jan; 267(3):783-90. PubMed ID: 10673369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative folding of peptides with cystine-knot architectures: kinetic studies and optimization of folding conditions.
    Reinwarth M; Glotzbach B; Tomaszowski M; Fabritz S; Avrutina O; Kolmar H
    Chembiochem; 2013 Jan; 14(1):137-46. PubMed ID: 23229141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disulfide bond rearrangement during formation of the chorionic gonadotropin beta-subunit cystine knot in vivo.
    Wilken JA; Bedows E
    Biochemistry; 2004 May; 43(17):5109-18. PubMed ID: 15109270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical synthesis, backbone cyclization and oxidative folding of cystine-knot peptides: promising scaffolds for applications in drug design.
    Reinwarth M; Nasu D; Kolmar H; Avrutina O
    Molecules; 2012 Oct; 17(11):12533-52. PubMed ID: 23095896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Grafting of thrombopoietin-mimetic peptides into cystine knot miniproteins yields high-affinity thrombopoietin antagonists and agonists.
    Krause S; Schmoldt HU; Wentzel A; Ballmaier M; Friedrich K; Kolmar H
    FEBS J; 2007 Jan; 274(1):86-95. PubMed ID: 17147697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Min-21 and min-23, the smallest peptides that fold like a cystine-stabilized beta-sheet motif: design, solution structure, and thermal stability.
    Heitz A; Le-Nguyen D; Chiche L
    Biochemistry; 1999 Aug; 38(32):10615-25. PubMed ID: 10441159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic Cystine-Knot Miniproteins - Valuable Scaffolds for Polypeptide Engineering.
    Avrutina O
    Adv Exp Med Biol; 2016; 917():121-44. PubMed ID: 27236555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The structure of a two-disulfide intermediate assists in elucidating the oxidative folding pathway of a cyclic cystine knot protein.
    Cemazar M; Joshi A; Daly NL; Mark AE; Craik DJ
    Structure; 2008 Jun; 16(6):842-51. PubMed ID: 18547517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The T-knot motif revisited.
    Polticelli F; Pascarella S; Bordo D; Bolognesi M; Ascenzi P
    Biol Chem; 1999 Oct; 380(10):1247-50. PubMed ID: 10595590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.